| 摘要: |
| ［摘要］ 研究证实埃克替尼治疗表皮生长因子受体突变的非小细胞肺癌（NSCLC）患者疗效明确，并具有放疗增敏效果。国内有大量的研究表明埃克替尼联合放疗能显著提高NSCLC患者生存时间，特别是对老年患者或脑转移患者，且不良反应较小。因此，埃克替尼联合放疗有可能成为治疗晚期NSCLC患者的有效治疗手段。现对其相关研究进展作一综述。 |
| 关键词: 非小细胞肺癌 放射疗法 埃克替尼 |
| DOI：10.3969/j.issn.1674-3806.2017.05.29 |
| 分类号:R 734.2 |
| 基金项目: |
|
| Progress of research on Icotinib combined with radiotherapy for patients with advanced non-small-cell lung cancer |
|
GUO Hong-yun, JIA Ya-sen, FENG Guo-sheng
|
|
Graduate School, Guangxi University of Chinese Medicine, Nanning 530001, China
|
| Abstract: |
| ［Abstract］ Studies confirm that Icotinib is effective in the treatment of epidermal growth factor receptor（EGFR） mutations for the patients with advanced non-small- cell lung cancer（NSCLC）, and improves the curative effect of radiotherapy. A large number data of domestic studies show that Icotinib combined with radiotherapy can significantly improve the survival time for the patients, especially for the elderly patients or those with brain metastases. The combined therapy has less adverse reactions and improves the qualitiy of life, and will be an effective treatment for the patients with advanced NSCLC. |
| Key words: Non-small-cell lung cancer(NSCLC) Radiotherapy Icotinib |
